Please assess the completion status of the following clinical trial:

Trial Title: The Indian POLYCAP Study (TIPS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 9.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 45 and 80 years~* At least any one of the following CVD risk factors:~  * Stable type 2 diabetes mellitus or~ * Hypertension or~ * Current smoker or~ * A waist to hip ratio \> 0.85 for women and \>0.9 for men or~ * Elevated lipids.~* Informed consent.~Exclusion Criteria:~* On any of the study medications,~* Uncontrolled blood pressure,~* Symptomatic hypotension,~* Any clear indication or a contraindication to the use of any of the study medications,~* History of coronary/cerebrovascular events,~* Pregnancy or lactating or women of child-bearing potential with inadequate contraception and / or an inability to attend follow up visits.

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1, POLYCAP (Type: EXPERIMENTAL): Combination of 3 anti hypertensives, lipid lowering agent and anti platelet agent
- 2 B (Type: ACTIVE_COMPARATOR): Diuretic antihypertensive
- 3 C (Type: ACTIVE_COMPARATOR): Thiazide plus Angiotensis converting enzyme inhibitor - combination antihypertensive.
- 4 D (Type: ACTIVE_COMPARATOR): Diuretic with Beta blocker combination antihypertensive
- 5, E (Type: ACTIVE_COMPARATOR): ACE inhibitor plus Beta blocker combination antihypertensive
- 6, F (Type: ACTIVE_COMPARATOR): Combination antihypertensive of ACE inhibitor, diuretic and beta blocker
- 7,G (Type: ACTIVE_COMPARATOR): Combination of ACE inhibitor, betablocker, diuretic and Antiplatelet
- 8,H (Type: ACTIVE_COMPARATOR): Lipid lowering agent
- 9,A (Type: ACTIVE_COMPARATOR): Antiplatelet

Based on this trial design, predict the completion outcome and termination type (if applicable).